We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...

Amylin is a hormone released by the pancreas ... This type of weight loss surgery changes the structure of your digestive system. There are several types of bariatric surgery, but the Roux-en ...

Imagine a breakthrough in cancer treatment where only malignant cells are targeted, sparing healthy host cells; or patients ...

Protein translocation is an essential, nano-scale dynamic process that facilitates the movement of proteins across cellular ...

Now researchers from The Rockefeller University have unearthed intriguing genetic evidence: a protein variant found only in humans that may have helped shape the emergence of spoken language.

Jonathan Wolleben’s rating is based on the significant potential he sees in Structure Therapeutics, Inc., particularly due to its position as a leader in small molecule amylin agonists.

Advancements in machine learning are reshaping protein structure prediction, offering efficient tools that enhance drug ...

Protein is kind of the It Girl of nutrients right now. It's the macro that's good at everything: building muscle, supporting immune function, sustaining energy levels, shoring up bone health, and ...

You don’t need to give up steaks entirely. But mounting evidence shows that a diet that incorporates more plant-based protein has a surprisingly large number of benefits for your health.

From raw eggs to protein shakes, those hoping to expand their brawn are often encouraged to ingest vast quantities of protein. But how much is really necessary and what's the best way to consume it?

Novo Nordisk’s NVO amycretin, which targets GLP-1 and amylin in one molecule, generated 24% placebo-adjusted weight loss in a phase 1b/2a study in patients with obesity or overweight after 36 ...